» Authors » Tarek Alsaied

Tarek Alsaied

Explore the profile of Tarek Alsaied including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 150
Citations 1032
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Karolcik B, Wang L, Ragavan M, Hoskoppal A, Saraf A, Arora G, et al.
Pediatr Cardiol . 2024 Dec; PMID: 39738672
The Child Opportunity Index (COI) is a validated measurement that uses a composite index of 29 indicators of social determinants of health linked to the US Census. Patients post-Fontan palliation...
2.
Truong V, Moore R, Lubert A, Taylor M, Mazur W, Alsaied T, et al.
Int J Cardiol Congenit Heart Dis . 2024 Dec; 7:100321. PMID: 39712285
Background: Myocardial fibrosis is a common final pathway in many myocardial diseases. Circulating biomarkers are recognized in heart failure management as potential treatment targets. The current study sought to evaluate...
3.
Alsaied T, Castrillon C, Christopher A, da Silva J, Morell V, Lanford L, et al.
Int J Cardiol Congenit Heart Dis . 2024 Dec; 7:100342. PMID: 39712277
Introduction: Despite the clinical benefits of the cone operation for Ebstein's anomaly, significant right ventricular (RV) dysfunction is frequently seen immediately after the procedure and if persistent may portend worse...
4.
Alsaied T, Lubert A, Goldberg D, Schumacher K, Rathod R, Katz D, et al.
Int J Cardiol Congenit Heart Dis . 2024 Dec; 7:100338. PMID: 39712273
The Fontan or Fontan Kreutzer procedure is the culmination of staged, surgical palliation of functional single ventricle congenital heart disease, offering the potential for survival and good quality of life...
5.
Karolcik B, Calcaterra M, Smith K, Schiff M, Ragavan M, Alsaied T, et al.
Pediatr Cardiol . 2024 Nov; PMID: 39601833
To assess the relationship between the Child Opportunity Index (COI), a validated measure that uses 29 indicators of social determinants of health linked to the US Census, and pediatric supraventricular...
6.
Wolfe N, Schiff M, Olivieri L, Christopher A, Fogel M, Slesnick T, et al.
J Am Coll Cardiol . 2024 Oct; 84(25):2417-2426. PMID: 39453360
Background: Among patients with congenital heart disease, those with single ventricles have the highest risk of early mortality. Sudden cardiac death is an important cause of death in this population....
7.
Alsaied T, Li R, Christopher A, Fogel M, Slesnick T, Krishnamurthy R, et al.
J Cardiovasc Magn Reson . 2024 Oct; 26(2):101113. PMID: 39442671
Background: Cardiac magnetic resonance (CMR) offers valuable hemodynamic insights post-Fontan, but is limited by the absence of normative single ventricle data. The Fontan Outcomes Registry using CMR Examinations (FORCE) is...
8.
Alsaied T, Li R, Christopher A, Fogel M, Slesnick T, Krishnamurthy R, et al.
JACC Adv . 2024 Sep; 3(10):101254. PMID: 39309667
Background: Fontan patients exhibit decreased exercise capacity. However, there is a subset of high-performing Fontan (HPF) patients with excellent exercise capacity. Objectives: This study aims to: 1) create a Fontan-specific...
9.
Ashraf S, Da Silva J, Castro-Medina M, Viegas M, Alsaied T, Seese L, et al.
J Thorac Cardiovasc Surg . 2024 Aug; 169(2):354-361.e3. PMID: 39181444
Background: We present a case series of right ventricle (RV) rehabilitation after the Starnes procedure in patients with Ebstein anomaly (EA), applying the Cone repair of the tricuspid valve (TV)...
10.
Bright C, Rizvi A, Ezekwueme F, Schiff M, Kliner J, Hindes M, et al.
Int J Cardiol . 2024 Aug; 414:132413. PMID: 39098615
Background: Guideline-directed heart failure therapy with angiotensin receptor blocker/neprilysin inhibitor (ARNi) and sodium-glucose transporter inhibitors (SGLT2i) has been incrementally beneficial in improving outcomes in heart failure patients. Objective: Evaluate the...